AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,663,961 | +9.9% | 89,575 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $2,423,900 | -37.9% | 89,575 | -50.0% | 0.01% | +12.5% |
Q3 2022 | $3,901,944 | -21.3% | 179,150 | -1.2% | 0.01% | -11.1% |
Q2 2022 | $4,959,055 | -35.2% | 181,350 | -20.6% | 0.01% | -18.2% |
Q1 2022 | $7,651,700 | +87.2% | 228,400 | +93.7% | 0.01% | +10.0% |
Q4 2021 | $4,088,000 | +0.9% | 117,900 | -9.2% | 0.01% | -9.1% |
Q3 2021 | $4,053,000 | -57.1% | 129,900 | -50.0% | 0.01% | -21.4% |
Q2 2021 | $9,448,000 | +637.0% | 259,800 | +786.7% | 0.01% | +250.0% |
Q1 2021 | $1,282,000 | +11.4% | 29,300 | -15.4% | 0.00% | 0.0% |
Q3 2020 | $1,151,000 | -53.2% | 34,636 | -58.7% | 0.00% | -20.0% |
Q2 2020 | $2,462,000 | +9.1% | 83,800 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $2,256,000 | -10.0% | 83,800 | +12.6% | 0.01% | +20.0% |
Q4 2019 | $2,508,000 | +4.0% | 74,400 | +15.5% | 0.01% | 0.0% |
Q3 2019 | $2,412,000 | +1.3% | 64,400 | +17.9% | 0.01% | 0.0% |
Q2 2019 | $2,382,000 | – | 54,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 1,991,583 | $86,853,000 | 6.59% |
Palmer Knight Co | 82,642 | $3,604,000 | 3.11% |
RGM Capital, LLC | 751,523 | $32,774,000 | 2.36% |
Sandhill Capital Partners LLC | 397,462 | $17,333,000 | 2.20% |
BROADVIEW ADVISORS LLC | 123,838 | $5,401,000 | 1.67% |
MOODY ALDRICH PARTNERS LLC | 93,736 | $4,088,000 | 1.04% |
Champlain Investment Partners, LLC | 2,455,532 | $107,086,000 | 0.90% |
Krensavage Asset Management, LLC | 59,378 | $2,589,000 | 0.84% |
RICE HALL JAMES & ASSOCIATES, LLC | 444,973 | $19,405,000 | 0.64% |
PURA VIDA INVESTMENTS, LLC | 85,000 | $3,707,000 | 0.56% |